Journal of Clinical Oncology

Vol. 44, Issue 19_suppl Issue 19_suppl 2026
340
Articles

Articles in this Issue

Impact of nurse-initiated early telephone follow-up on unplanned 30-day hospital admissions after first-cycle chemotherapy: A real-world implementation study.

Pimsiri Aksornrung Jul 01, 2026 pp. 326-326 10.1200/jco.2026.44.19_suppl.326

326 Background: Patients receiving chemotherapy may experience treatment-related side effects after discharge, particularl...

Heart failure–related mortality in patients with breast cancer: A 26-year national surveillance study (1999–2024).

Muhammad Hassan Ashraf Rai, Mazhar Ali, Muhammad Atif Mazhar et al. Jul 01, 2026 pp. 43-43 10.1200/jco.2026.44.19_suppl.43

43 Background: Heart failure (HF) is a recognized comorbidity in breast cancer patients, affecting both survival and quali...

Interaction of DLL3-targeting CAR-T cells with the JAK1 inhibitor in treating small cell lung cancer.

Mengwei Li, Hua Zhong Jul 01, 2026 pp. 286-286 10.1200/jco.2026.44.19_suppl.286

286 Background: Small cell lung cancer (SCLC) is an aggressive malignancy with limited effective treatment options. DLL3-t...

Real-world experience with second and third generation tyrosine kinase inhibitors in imatinib-resistant Nigerian patients with BCR::ABL1 positive chronic myeloid leukaemia.

Ibrahim Oluwaseun Ahmed, Temilola Owojuyigbe, Olusola Joseph Olarewaju et al. Jul 01, 2026 pp. 255-255 10.1200/jco.2026.44.19_suppl.255

255 Background: Imatinib significantly advances CML management, inducing deep molecular response and increasing survival....

TMEM132A to promote cervical cancer progression via HOMER3-mediated activation of FAK/PI3K/AKT signaling pathway.

Fengyi Sun, Xuechao Ji Jul 01, 2026 pp. 223-223 10.1200/jco.2026.44.19_suppl.223

223 Background: TMEM132A exhibits aberrant expression in various types of solid tumors. However, its biological roles and...

Surgical outcomes and recurrence risk factors for rectal gastrointestinal stromal tumors: A comparison of transabdominal and transanal resection.

Ran Xiong, Xiangfei Sun, Yaoyu Hong et al. Jul 01, 2026 pp. 114-114 10.1200/jco.2026.44.19_suppl.114

114 Background: Rectal gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms that present unique surgical...

Efficacy of melatonin supplementation for sleep quality, depression, and fatigue in patients with breast cancer: A systematic review and meta-analysis.

Melisha Koirala, Aakash Pandit Jul 01, 2026 pp. 55-55 10.1200/jco.2026.44.19_suppl.55

55 Background: Breast cancer patients frequently experience a cluster of debilitating symptoms, including sleep disturbanc...

The prognostic significance of MYBL1 and MYBL2 genes in low-grade glioma.

Abdallah Al-Ramadi, Jehad A. Yasin, Ahmad Shawabkeh et al. Jul 01, 2026 pp. 73-73 10.1200/jco.2026.44.19_suppl.73

73 Background: Low-grade gliomas (LGG) demonstrate heterogeneous clinical behavior despite shared histologic classificatio...

Artificial intelligence–assisted colonoscopy and adenoma detection: An updated systematic review and meta-analysis of 42 studies.

Shabih Raza Farista, Mazhar Ali, Mohammad Dawar Zahid et al. Jul 01, 2026 pp. 2-2 10.1200/jco.2026.44.19_suppl.2

2 Background: Colonoscopy misses a meaningful proportion of adenomas, limiting preventive effectiveness. We updated the ev...

Prospective study of quantitative broadband diffuse optical spectroscopy for differential diagnosis of suspicious breast lesions.

Alice Marie Police, Roy Stillwell, Christopher A. Campbell et al. Jul 01, 2026 pp. 31-31 10.1200/jco.2026.44.19_suppl.31

31 Background: A definitive breast cancer diagnosis requires a biopsy. However, suspicious lesions classified BI-RADS 3 an...

Latent profiles of digital health technophobia and associated factors among older adults with cancer.

Yingtao Meng, Junyi Peng, Jiayi Dai Jul 01, 2026 pp. 354-354 10.1200/jco.2026.44.19_suppl.354

354 Background: As digital health technologies become increasingly embedded in oncology care, older adults with cancer are...

Tri-marker model integrating BCL2A1 expression in CD8⁺ T cells, PD-L1, and HOT score as a predictor of immune checkpoint blockade response in lung adenocarcinoma: A multi-cohort integrative analysis.

Hoang Minh Quan Pham Jul 01, 2026 pp. 291-291 10.1200/jco.2026.44.19_suppl.291

291 Background: Despite advances in immune checkpoint blockade (ICB) for advanced lung adenocarcinoma (LUAD), predictive b...

Real-world effectiveness and safety of amivantamab plus chemotherapy versus chemotherapy alone in EGFR-mutant NSCLC after osimertinib: A propensity score–matched analysis.

Shankar Biswas, Yashasvi Srivastava, Rahul Falodia et al. Jul 01, 2026 pp. 284-284 10.1200/jco.2026.44.19_suppl.284

284 Background: Amivantamab plus carboplatin–pemetrexed was approved (Sep 2024) for EGFR-mutant advanced NSCLC post-osimer...

Translational advancement of HCB101, a third-generation SIRPα–Fc ligand trap targeting the CD47-SIRPα axis: Integrated phase 1 monotherapy and phase 1b/2a combination development.

Fangling Ning, Nicholas Iannotti, Wei-Hong Cheng et al. Jul 01, 2026 10.1200/jco.2026.44.19_suppl.tps89

TPS89 Background: The CD47–SIRPα axis functions as a central innate immune checkpoint that suppresses macrophage-mediated...

Psychosocial distress and health-related quality of life in women undergoing active treatment for breast and gynaecological cancers: A cross-sectional analysis.

Ankur Bahl, Aarushi Saluja, Nitesh Rohatgi et al. Jul 01, 2026 pp. 330-330 10.1200/jco.2026.44.19_suppl.330

330 Background: Despite advances in systemic therapy, psychosocial distress during active cancer treatment remains under-r...

RelB/ILF2–GM-CSF loop to sustain MDSC-mediated prostate cancer immunosuppression.

Yanyan Zhang Jul 01, 2026 pp. 105-105 10.1200/jco.2026.44.19_suppl.105

105 Background: Prostate cancer (PCa) is characterized by an immunologically “cold” tumor microenvironment (TME), with pro...

Early results from a phase 1/2 clinical study of a urine-based multi-cancer early detection (MCED) assay for prostate, bladder, and kidney cancers.

Kenneth Chen, Maybelline Tan, Sandy Lim et al. Jul 01, 2026 pp. 181-181 10.1200/jco.2026.44.19_suppl.181

181 Background: Current diagnostic pathways for kidney, bladder and prostate cancers rely on invasive procedures and imagi...

Availability and reimbursement of systemic therapies for the five most common cancers in Vietnam: A national landscape analysis.

Giang Hoang Pham, Thang Van Nguyen, Mai Thi Hoang et al. Jul 01, 2026 pp. 329-329 10.1200/jco.2026.44.19_suppl.329

329 Background: Access to evidence-based systemic anticancer therapies remains uneven in many low- and middle-income count...

Adebrelimab combined with oral etoposide for older patients and patients with poor performance status In small cell lung cancer: A multicenter, open-label, phase II clinical study.

Fang Liu, Meng Hong Xue, Yan Zhang et al. Jul 01, 2026 10.1200/jco.2026.44.19_suppl.tps293

TPS293 Background: Small cell lung cancer (SCLC) is a highly aggressive, high-grade neuroendocrine carcinoma characterized...

Liver resection in a resource-limited setting: Outcome of developed-world standards of R0 resection and 30-day mortality without a dedicated ICU or advanced technology—A real-world data analysis from Sri Lanka.

Sampath Hirantha Herath, Niroshan S. Atulugama, Chathuri udeshika Goonetilleke et al. Jul 01, 2026 pp. 344-344 10.1200/jco.2026.44.19_suppl.344

344 Background: Liver resection with curative intent offers a chance of long-term survival for patients with hepatic malig...

Real-world outcomes of first-line afatinib in advanced non–small cell lung cancer patients with uncommon EGFR mutations at Vietnam National Cancer Hospital.

Anh Tuan Nguyen Jul 01, 2026 pp. 277-277 10.1200/jco.2026.44.19_suppl.277

277 Background: Uncommon EGFR mutations represent a heterogeneous subgroup of non–small cell lung cancer (NSCLC) with vari...

Nimotuzumab combined with induction chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A prospective, multicenter, randomized controlled trial—Preliminary analysis.

Chen Xi Shan, Wu Yu Zhen, Lu Ying Jul 01, 2026 pp. 238-238 10.1200/jco.2026.44.19_suppl.238

238 Background: To evaluate nimotuzumab combined with standard chemoradiotherapy in locally advanced nasopharyngeal carcin...

Integrative immune-genomic profiling for identification of treatment-relevant phenotypes association with predicted sensitivity to neoadjuvant chemo-immunotherapy in muscle-invasive bladder cancer.

Onyekachi Anya, Ogbonna Chikere, Oluchi Idenyi et al. Jul 01, 2026 pp. 183-183 10.1200/jco.2026.44.19_suppl.183

183 Background: Neoadjuvant chemo-immunotherapy is an emerging strategy for muscle-invasive bladder cancer (MIBC), yet res...

Comprehensive geriatric assessment to predict 30-day postoperative morbidity in elderly patients undergoing curative surgery for oral squamous cell carcinoma: A prospective observational study.

Anoop Attakkil, Ferhana Malieckal Jul 01, 2026 pp. 230-230 10.1200/jco.2026.44.19_suppl.230

230 Background: Chronological age alone is an inadequate predictor of surgical outcomes in elderly patients with oral squa...

Single-cell atlas and the role of sex hormones and chromosomes in sex-divergent reprogramming of the tumor microenvironment.

Ning Kang Jul 01, 2026 pp. 174-174 10.1200/jco.2026.44.19_suppl.174

174 Background: Sex bias is pervasive in tumors; however, the contributions of sex chromosomes and hormones to reprogrammi...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page